Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription Articles published in Cancer Retrieve available abstracts of 106 articles: HTML format Text format

Single Articles

May 2018
1. MEESTER RGS, Peterse EFP, Knudsen AB, de Weerdt AC, et al
   Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline.
   Cancer. 2018 May 30. doi: 10.1002/cncr.31542.
   PubMed     Text format     Abstract available
   
   
   
2. PETERSE EFP, Meester RGS, Siegel RL, Chen JC, et al
   The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.
   Cancer. 2018 May 30. doi: 10.1002/cncr.31543.
   PubMed     Text format     Abstract available
   
   
   
3. KROENKE CH, Prado CM, Meyerhardt JA, Weltzien EK, et al
   Muscle radiodensity and mortality in patients with colorectal cancer.
   Cancer. 2018 May 24. doi: 10.1002/cncr.31405.
   PubMed     Text format     Abstract available
   
   
   April 2018
4. AZAR I, Esfandiarifard S, Sinai P, Mehdi S, et al
   Colon cancer survival in the US Department of Veterans Affairs by race and stage: 2001 through 2009.
   Cancer. 2018 Apr 30. doi: 10.1002/cncr.31525.
   PubMed     Text format    
   
   
   
5. WHITE A, Rim SH, Joseph DA, Johnson CJ, et al
   Reply to Colon cancer survival in the US Department of Veterans Affairs by race and stage: 2001 through 2009.
   Cancer. 2018 Apr 30. doi: 10.1002/cncr.31523.
   PubMed     Text format    
   
   
   
6. KARUTURI MS, Holmes HM, Lei X, Johnson M, et al
   Potentially inappropriate medication use in older patients with breast and colorectal cancer.
   Cancer. 2018 Apr 24. doi: 10.1002/cncr.31403.
   PubMed     Text format     Abstract available
   
   
   
7. ALATISE OI, Ayandipo OO, Adeyeye A, Seier K, et al
   A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of patients at high risk for colorectal cancer.
   Cancer. 2018 Apr 12. doi: 10.1002/cncr.31399.
   PubMed     Text format     Abstract available
   
   
   
8. MOLS F, Schoormans D, de Hingh I, Oerlemans S, et al
   Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: Prevalence, predictors, and impact on quality of life.
   Cancer. 2018 Apr 6. doi: 10.1002/cncr.31369.
   PubMed     Text format     Abstract available
   
   
   
9. TSOH JY, Tong EK, Sy AU, Stewart SL, et al
   Knowledge of colorectal cancer screening guidelines and intention to obtain screening among nonadherent Filipino, Hmong, and Korean Americans.
   Cancer. 2018;124 Suppl 7:1560-1567.
   PubMed     Text format     Abstract available
   
   
   
10. CUARESMA CF, Sy AU, Nguyen TT, Ho RCS, et al
    Results of a lay health education intervention to increase colorectal cancer screening among Filipino Americans: A cluster randomized controlled trial.
    Cancer. 2018;124 Suppl 7:1535-1542.
    PubMed     Text format     Abstract available
    
    
    
11. SY AU, Lim E, Ka'opua LS, Kataoka-Yahiro M, et al
    Colorectal cancer screening prevalence and predictors among Asian American subgroups using Medical Expenditure Panel Survey National Data.
    Cancer. 2018;124 Suppl 7:1543-1551.
    PubMed     Text format     Abstract available
    
    
    
12. TRAN MT, Jeong MB, Nguyen VV, Sharp MT, et al
    Colorectal cancer beliefs, knowledge, and screening among Filipino, Hmong, and Korean Americans.
    Cancer. 2018;124 Suppl 7:1552-1559.
    PubMed     Text format     Abstract available
    
    
    
13. SUN A, Tsoh JY, Tong EK, Cheng J, et al
    A physician-initiated intervention to increase colorectal cancer screening in Chinese patients.
    Cancer. 2018;124 Suppl 7:1568-1575.
    PubMed     Text format     Abstract available
    
    
    March 2018
14. BLACK DS, Cole SW, Christodoulou G, Figueiredo JC, et al
    Genomic mechanisms of fatigue in survivors of colorectal cancer.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31356.
    PubMed     Text format     Abstract available
    
    
    
15. POLITE BN, Cipriano-Steffens TM, Hlubocky FJ, Jean-Pierre P, et al
    Association of externalizing religious and spiritual beliefs on stage of colon cancer diagnosis among black and white multicenter urban patient populations.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31351.
    PubMed     Text format     Abstract available
    
    
    
16. PISHVAIAN MJ, Slack RS, Jiang W, He AR, et al
    A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31309.
    PubMed     Text format     Abstract available
    
    
    February 2018
17. EBERTH JM, Thibault A, Caldwell R, Josey MJ, et al
    A statewide program providing colorectal cancer screening to the uninsured of South Carolina.
    Cancer. 2018 Feb 7. doi: 10.1002/cncr.31250.
    PubMed     Text format     Abstract available
    
    
    January 2018
18. ROSS JS, Fakih M, Ali SM, Elvin JA, et al
    Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31125.
    PubMed     Text format     Abstract available
    
    
    
19. PRINTZ C
    Death rates for colorectal cancer rising for individuals aged younger than 55 years.
    Cancer. 2018;124:229.
    PubMed     Text format    
    
    
    
20. RILEY JM, Cross AW, Paulos CM, Rubinstein MP, et al
    The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine.
    Cancer. 2018 Jan 9. doi: 10.1002/cncr.31214.
    PubMed     Text format     Abstract available
    
    
    
21. PRINTZ C
    Study finds link between inflammation and colorectal cancer.
    Cancer. 2018;124:13.
    PubMed     Text format    
    
    
    
22. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    PubMed     Text format     Abstract available
    
    
    December 2017
23. WHITE A, Joseph D, Rim SH, Johnson CJ, et al
    Colon cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5014-5036.
    PubMed     Text format     Abstract available
    
    
    
24. JOSEPH DA, Johnson CJ, White A, Wu M, et al
    Rectal cancer survival in the United States by race and stage, 2001 to 2009: Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5037-5058.
    PubMed     Text format     Abstract available
    
    
    
25. DOROUDI M, Schoen RE, Pinsky PF
    Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality?
    Cancer. 2017;123:4815-4822.
    PubMed     Text format     Abstract available
    
    
    
26. MEROPOL NJ, Feng Y, Grem JL, Mulcahy MF, et al
    Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203).
    Cancer. 2017 Dec 6. doi: 10.1002/cncr.30967.
    PubMed     Text format     Abstract available
    
    
    
27. NIXON NA, Khan OF, Imam H, Tang PA, et al
    Drug development for breast, colorectal, and non-small cell lung cancers from 1979 to 2014.
    Cancer. 2017;123:4672-4679.
    PubMed     Text format     Abstract available
    
    
    November 2017
28. TRICOLI JV, Boardman LA, Patidar R, Sindiri S, et al
    A mutational comparison of adult and adolescent and young adult (AYA) colon cancer.
    Cancer. 2017 Nov 30. doi: 10.1002/cncr.31136.
    PubMed     Text format     Abstract available
    
    
    
29. SARMA EA, Kawachi I, Poole EM, Tworoger SS, et al
    Social integration and survival after diagnosis of colorectal cancer.
    Cancer. 2017 Nov 21. doi: 10.1002/cncr.31117.
    PubMed     Text format     Abstract available
    
    
    
30. ZHAO H, Zhang N, Ho V, Ding M, et al
    Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
    Cancer. 2017 Nov 15. doi: 10.1002/cncr.31094.
    PubMed     Text format     Abstract available
    
    
    
31. CASSIDY RJ, Switchenko JM, Cheng E, Jiang R, et al
    Health care disparities among octogenarians and nonagenarians with stage II and III rectal cancer.
    Cancer. 2017;123:4325-4336.
    PubMed     Text format     Abstract available
    
    
    
32. ZHANG J, Raju GS, Chang DW, Lin SH, et al
    Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31062.
    PubMed     Text format     Abstract available
    
    
    October 2017
33. PRINTZ C
    Some stage III colon cancer patients may need only half of the standard chemotherapy course.
    Cancer. 2017;123:3871.
    PubMed     Text format    
    
    
    
34. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
    Psychological distress associated with cancer screening: A systematic review.
    Cancer. 2017;123:3882-3894.
    PubMed     Text format     Abstract available
    
    
    
35. LEVI Z, Kark JD, Katz LH, Twig G, et al
    Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: A population-based study.
    Cancer. 2017;123:4022-4030.
    PubMed     Text format     Abstract available
    
    
    
36. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    PubMed     Text format     Abstract available
    
    
    
37. SEGNAN N, Armaroli P
    Early detection versus prevention in colorectal cancer screening: Methods estimates and public health implications.
    Cancer. 2017 Oct 4. doi: 10.1002/cncr.31032.
    PubMed     Text format    
    
    
    
38. HONG YR, Tauscher J, Cardel M
    Distrust in health care and cultural factors are associated with uptake of colorectal cancer screening in Hispanic and Asian Americans.
    Cancer. 2017 Oct 4. doi: 10.1002/cncr.31052.
    PubMed     Text format     Abstract available
    
    
    September 2017
39. DESHMUKH AA, Chiao EY, Cantor SB, Stier EA, et al
    Management of precancerous anal intraepithelial lesions in human immunodeficiency virus-positive men who have sex with men: Clinical effectiveness and cost-effectiveness.
    Cancer. 2017 Sep 26. doi: 10.1002/cncr.31035.
    PubMed     Text format     Abstract available
    
    
    
40. CESPEDES FELICIANO EM, Lee VS, Prado CM, Meyerhardt JA, et al
    Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study.
    Cancer. 2017 Sep 7. doi: 10.1002/cncr.30950.
    PubMed     Text format     Abstract available
    
    
    
41. SADETZKI S, Chetrit A, Freedman LS, Hakak N, et al
    Cancer risk among Holocaust survivors in Israel-A nationwide study.
    Cancer. 2017;123:3335-3345.
    PubMed     Text format     Abstract available
    
    
    August 2017
42. KOCARNIK JM, Hua X, Hardikar S, Robinson J, et al
    Long-term weight loss after colorectal cancer diagnosis is associated with lower survival: The Colon Cancer Family Registry.
    Cancer. 2017 Aug 25. doi: 10.1002/cncr.30932.
    PubMed     Text format     Abstract available
    
    
    
43. MEDHANIE GA, Fedewa SA, Adissu H, DeSantis CE, et al
    Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks.
    Cancer. 2017;123:3116-3124.
    PubMed     Text format     Abstract available
    
    
    
44. PRINTZ C
    Sulfide-producing bacteria linked to higher colon cancer risk in African Americans.
    Cancer. 2017;123:2795.
    PubMed     Text format    
    
    
    
45. JAGAI JS, Messer LC, Rappazzo KM, Gray CL, et al
    County-level cumulative environmental quality associated with cancer incidence.
    Cancer. 2017;123:2901-2908.
    PubMed     Text format     Abstract available
    
    
    
46. MALAPELLE U, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, et al
    Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.
    Cancer. 2017;125:615-626.
    PubMed     Text format     Abstract available
    
    
    July 2017
47. GREEN BB, Anderson ML, Cook AJ, Chubak J, et al
    A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: A randomized trial.
    Cancer. 2017 Jul 28. doi: 10.1002/cncr.30908.
    PubMed     Text format     Abstract available
    
    
    
48. PRINTZ C
    Physicians discuss genetic testing for and treatment of colorectal cancer.
    Cancer. 2017;123:2591-2593.
    PubMed     Text format    
    
    
    
49. LIN SC, McKinley D, Sripipatana A, Makaroff L, et al
    Colorectal cancer screening at US community health centers: Examination of sociodemographic disparities and association with patient-provider communication.
    Cancer. 2017 Jul 14. doi: 10.1002/cncr.30855.
    PubMed     Text format     Abstract available
    
    
    
50. OKAZAKI S, Schirripa M, Loupakis F, Cao S, et al
    Tandem repeat variation near the HIC1 (hypermethylated in cancer 1) promoter predicts outcome of oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
    Cancer. 2017 Jul 14. doi: 10.1002/cncr.30880.
    PubMed     Text format     Abstract available
    
    
    
51. SHARP L, McDevitt J, Brown C, Carsin AE, et al
    Association between smoking at diagnosis and cause-specific survival in patients with rectal cancer: Results from a population-based analysis of 10,794 cases.
    Cancer. 2017;123:2543-2550.
    PubMed     Text format     Abstract available
    
    
    
52. LEWIS DR, Chen HS, Cockburn MG, Wu XC, et al
    Early estimates of SEER cancer incidence, 2014.
    Cancer. 2017;123:2524-2534.
    PubMed     Text format     Abstract available
    
    
    June 2017
53. RICKER CN, Hanna DL, Peng C, Nguyen NT, et al
    DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30790.
    PubMed     Text format     Abstract available
    
    
    
54. LONG Y, Sanchez-Espiridion B, Lin M, White L, et al
    Global and targeted serum metabolic profiling of colorectal cancer progression.
    Cancer. 2017 Jun 22. doi: 10.1002/cncr.30829.
    PubMed     Text format     Abstract available
    
    
    
55. HILLYER GC, Jensen CD, Zhao WK, Neugut AI, et al
    Primary care visit use after positive fecal immunochemical test for colorectal cancer screening.
    Cancer. 2017 Jun 16. doi: 10.1002/cncr.30809.
    PubMed     Text format     Abstract available
    
    
    May 2017
56. LEE DW, Han SW, Cha Y, Bae JM, et al
    Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer.
    Cancer. 2017 May 17. doi: 10.1002/cncr.30760.
    PubMed     Text format     Abstract available
    
    
    
57. PARTIN MR, Gravely AA, Burgess JF Jr, Haggstrom DA, et al
    Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.
    Cancer. 2017 May 11. doi: 10.1002/cncr.30765.
    PubMed     Text format     Abstract available
    
    
    
58. RICE K, Gressard L, DeGroff A, Gersten J, et al
    Increasing colonoscopy screening in disparate populations: Results from an evaluation of patient navigation in the New Hampshire Colorectal Cancer Screening Program.
    Cancer. 2017 May 2. doi: 10.1002/cncr.30761.
    PubMed     Text format     Abstract available
    
    
    
59. LUDMIR EB, Palta M, Willett CG, Czito BG, et al
    Total neoadjuvant therapy for rectal cancer: An emerging option.
    Cancer. 2017;123:1497-1506.
    PubMed     Text format     Abstract available
    
    
    
60. SUN Z, Ke X, Salzberg SL, Kim D, et al
    The novel fusion transcript NR5A2-KLHL29FT is generated by an insertion at the KLHL29 locus.
    Cancer. 2017;123:1507-1515.
    PubMed     Text format     Abstract available
    
    
    
61. COOPER GS, Kou TD, Dor A, Koroukian SM, et al
    Cancer preventive services, socioeconomic status, and the Affordable Care Act.
    Cancer. 2017;123:1585-1589.
    PubMed     Text format     Abstract available
    
    
    April 2017
62. JO AM, Nguyen TT, Stewart S, Sung MJ, et al
    Lay health educators and print materials for the promotion of colorectal cancer screening among Korean Americans: A randomized comparative effectiveness study.
    Cancer. 2017 Apr 25. doi: 10.1002/cncr.30568.
    PubMed     Text format     Abstract available
    
    
    
63. MOWERY YM, Salama JK, Zafar SY, Moore HG, et al
    Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.
    Cancer. 2017;123:1434-1441.
    PubMed     Text format     Abstract available
    
    
    
64. BLACK DS, Peng C, Sleight AG, Nguyen N, et al
    Mindfulness practice reduces cortisol blunting during chemotherapy: A randomized controlled study of colorectal cancer patients.
    Cancer. 2017 Apr 7. doi: 10.1002/cncr.30698.
    PubMed     Text format     Abstract available
    
    
    March 2017
65. MERCHANT SJ, Nanji S, Brennan K, Karim S, et al
    Management of stage III colon cancer in the elderly: Practice patterns and outcomes in the general population.
    Cancer. 2017 Mar 27. doi: 10.1002/cncr.30691.
    PubMed     Text format     Abstract available
    
    
    
66. CASSIDY RJ, Liu Y, Patel K, Zhong J, et al
    Can we eliminate neoadjuvant chemoradiotherapy in favor of neoadjuvant multiagent chemotherapy for select stage II/III rectal adenocarcinomas: Analysis of the National Cancer Data base.
    Cancer. 2017;123:783-793.
    PubMed     Text format     Abstract available
    
    
    February 2017
67. SEHDEV A, Sherer EA, Hui SL, Wu J, et al
    Patterns of computed tomography surveillance in survivors of colorectal cancer at Veterans Health Administration facilities.
    Cancer. 2017 Feb 17. doi: 10.1002/cncr.30569.
    PubMed     Text format     Abstract available
    
    
    
68. FRANKEL TL, Vakiani E, Nathan H, DeMatteo RP, et al
    Mutation location on the RAS oncogene affects pathologic features and survival after resection of colorectal liver metastases.
    Cancer. 2017;123:568-575.
    PubMed     Text format     Abstract available
    
    
    
69. SAHLMANN CO, Homayounfar K, Niessner M, Dyczkowski J, et al
    Repeated adjuvant anti-CEA radioimmunotherapy after resection of colorectal liver metastases: Safety, feasibility, and long-term efficacy results of a prospective phase 2 study.
    Cancer. 2017;123:638-649.
    PubMed     Text format     Abstract available
    
    
    
70. REDDY SK, Boland PM, Nurkin SJ
    Primary tumor resection does not improve survival among patients with unresectable colorectal cancer metastases-But who determines resectability?
    Cancer. 2017 Feb 8. doi: 10.1002/cncr.30595.
    PubMed     Text format    
    
    
    January 2017
71. YANG B, Gapstur SM, Newton CC, Jacobs EJ, et al
    Alcohol intake and mortality among survivors of colorectal cancer: The Cancer Prevention Study II Nutrition Cohort.
    Cancer. 2017 Jan 30. doi: 10.1002/cncr.30556.
    PubMed     Text format     Abstract available
    
    
    
72. BARZI A, Lenz HJ, Quinn DI, Sadeghi S, et al
    Comparative effectiveness of screening strategies for colorectal cancer.
    Cancer. 2017 Jan 24. doi: 10.1002/cncr.30518.
    PubMed     Text format     Abstract available
    
    
    
73. HSU T, Speers CH, Kennecke HF, Cheung WY, et al
    The utility of abbreviated patient-reported outcomes for predicting survival in early stage colorectal cancer.
    Cancer. 2017 Jan 12. doi: 10.1002/cncr.30511.
    PubMed     Text format     Abstract available
    
    
    
74. XU Z, Mohile SG, Tejani MA, Becerra AZ, et al
    Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis.
    Cancer. 2017;123:52-61.
    PubMed     Text format     Abstract available
    
    
    
75. AMINI A, Jones BL, Ghosh D, Schefter TE, et al
    Impact of facility volume on outcomes in patients with squamous cell carcinoma of the anal canal: Analysis of the National Cancer Data Base.
    Cancer. 2017;123:228-236.
    PubMed     Text format     Abstract available
    
    
    December 2016
76. HOFFMAN AS, Lowenstein LM, Kamath GR, Housten AJ, et al
    An entertainment-education colorectal cancer screening decision aid for African American patients: A randomized controlled trial.
    Cancer. 2016 Dec 21. doi: 10.1002/cncr.30489.
    PubMed     Text format     Abstract available
    
    
    
77. MULLER CJ, Robinson RF, Smith JJ, Jernigan MA, et al
    Text message reminders increased colorectal cancer screening in a randomized trial with Alaska Native and American Indian people.
    Cancer. 2016 Dec 21. doi: 10.1002/cncr.30499.
    PubMed     Text format     Abstract available
    
    
    
78. DAVIS SN, Christy SM, Chavarria EA, Abdulla R, et al
    A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30481.
    PubMed     Text format     Abstract available
    
    
    
79. GULATI R, Albertsen PC
    Insights from the PLCO trial about prostate cancer screening.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30472.
    PubMed     Text format    
    
    
    November 2016
80. GANESH K, Shah RH, Vakiani E, Nash GM, et al
    Clinical and genetic determinants of ovarian metastases from colorectal cancer.
    Cancer. 2016 Nov 22. doi: 10.1002/cncr.30424.
    PubMed     Text format     Abstract available
    
    
    
81. PHIPPS AI, Robinson JR, Campbell PT, Win AK, et al
    Prediagnostic alcohol consumption and colorectal cancer survival: The Colon Cancer Family Registry.
    Cancer. 2016 Nov 8. doi: 10.1002/cncr.30446.
    PubMed     Text format     Abstract available
    
    
    September 2016
82. DURCINOSKA I, Young JM, Solomon MJ
    Patterns and predictors of colorectal cancer care coordination: A population-based survey of Australian patients.
    Cancer. 2016 Sep 7. doi: 10.1002/cncr.30326.
    PubMed     Text format     Abstract available
    
    
    August 2016
83. TONG EK, Nguyen TT, Lo P, Stewart SL, et al
    Lay health educators increase colorectal cancer screening among Hmong Americans: A cluster randomized controlled trial.
    Cancer. 2016 Aug 26. doi: 10.1002/cncr.30265.
    PubMed     Text format     Abstract available
    
    
    
84. ALAWADI Z, Phatak UR, Hu CY, Bailey CE, et al
    Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer.
    Cancer. 2016 Aug 1. doi: 10.1002/cncr.30230.
    PubMed     Text format     Abstract available
    
    
    July 2016
85. CHRISTY SM, Davis SN, Williams KR, Zhao X, et al
    A community-based trial of educational interventions with fecal immunochemical tests for colorectal cancer screening uptake among blacks in community settings.
    Cancer. 2016 Jul 15. doi: 10.1002/cncr.30207.
    PubMed     Text format     Abstract available
    
    
    
86. CASADABAN L, Rauscher G, Aklilu M, Villenes D, et al
    Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
    Cancer. 2016 Jul 15. doi: 10.1002/cncr.30181.
    PubMed     Text format     Abstract available
    
    
    
87. VIJAYVERGIA N, Li T, Wong YN, Hall MJ, et al
    Chemotherapy use and adoption of new agents is affected by age and comorbidities in patients with metastatic colorectal cancer.
    Cancer. 2016 Jul 5. doi: 10.1002/cncr.30077.
    PubMed     Text format     Abstract available
    
    
    June 2016
88. LOWERY JT, Ahnen DJ, Schroy PC 3rd, Hampel H, et al
    Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review.
    Cancer. 2016 Jun 3. doi: 10.1002/cncr.30080.
    PubMed     Text format     Abstract available
    
    
    
89. ERENAY FS, Alagoz O, Banerjee R, Said A, et al
    Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence.
    Cancer. 2016 Jun 1. doi: 10.1002/cncr.30091.
    PubMed     Text format     Abstract available
    
    
    
90. VAN DER MEULEN MP, Lansdorp-Vogelaar I, van Heijningen EM, Kuipers EJ, et al
    Nonbleeding adenomas: Evidence of systematic false-negative fecal immunochemical test results and their implications for screening effectiveness-A modeling study.
    Cancer. 2016;122:1680-8.
    PubMed     Text format     Abstract available
    
    
    
91. WANG M, Aldubayan S, Connor AA, Wong B, et al
    Genetic testing for Lynch syndrome in the province of Ontario.
    Cancer. 2016;122:1672-9.
    PubMed     Text format     Abstract available
    
    
    
92. WEISS J, Grilley Olson J, Deal AM, Chera B, et al
    Using the galactose-alpha-1,3-galactose enzyme-linked immunosorbent assay to predict anaphylaxis in response to cetuximab.
    Cancer. 2016;122:1697-701.
    PubMed     Text format     Abstract available
    
    
    May 2016
93. LADABAUM U, Patel A, Mannalithara A, Sundaram V, et al
    Predicting advanced neoplasia at colonoscopy in a diverse population with the National Cancer Institute colorectal cancer risk-assessment tool.
    Cancer. 2016 May 24. doi: 10.1002/cncr.30096.
    PubMed     Text format     Abstract available
    
    
    
94. JOSEPH DA, Meester RG, Zauber AG, Manninen DL, et al
    Colorectal cancer screening: Estimated future colonoscopy need and current volume and capacity.
    Cancer. 2016 May 20. doi: 10.1002/cncr.30070.
    PubMed     Text format     Abstract available
    
    
    April 2016
95. AL MOUSTAFA AE, Al-Antary NT
    Specific gene patterns and molecular pathways related to human carcinogenesis in different populations among various geographic locations.
    Cancer. 2016;122:1134-5.
    PubMed     Text format    
    
    
    
96. SIRAJ AK, Beg S, Al-Kuraya KS
    Reply to specific gene patterns and molecular pathways related to human carcinogenesis in different populations among various geographic locations.
    Cancer. 2016;122:1135-7.
    PubMed     Text format    
    
    
    March 2016
97. MOR V, Joyce NR, Cote DL, Gidwani RA, et al
    The rise of concurrent care for veterans with advanced cancer at the end of life.
    Cancer. 2016;122:782-90.
    PubMed     Text format     Abstract available
    
    
    
98. WRIGHT BJ, Conlin AK, Allen HL, Tsui J, et al
    What does Medicaid expansion mean for cancer screening and prevention? Results from a randomized trial on the impacts of acquiring Medicaid coverage.
    Cancer. 2016;122:791-7.
    PubMed     Text format     Abstract available
    
    
    February 2016
99. CORDERO-MORALES A, Savitzky MJ, Stenning-Persivale K, Segura ER, et al
    Conceptual considerations and methodological recommendations for the use of the mortality-to-incidence ratio in time-lagged, ecological-level analysis for public health systems-oriented cancer research.
    Cancer. 2016;122:486-7.
    PubMed     Text format    
    
    
    
100. SUNKARA V, Hebert JR
     The application of the mortality-to-incidence ratio for the evaluation of cancer care disparities globally.
     Cancer. 2016;122:487-8.
     PubMed     Text format    
     
     
     
101. TEVAARWERK AJ, Lee JW, Terhaar A, Sesto ME, et al
     Working after a metastatic cancer diagnosis: Factors affecting employment in the metastatic setting from ECOG-ACRIN's Symptom Outcomes and Practice Patterns study.
     Cancer. 2016;122:438-46.
     PubMed     Text format     Abstract available
     
     
     
102. STOVER AM, Basch EM
     Using patient-reported outcome measures as quality indicators in routine cancer care.
     Cancer. 2016;122:355-7.
     PubMed     Text format    
     
     
     
103. SMITH TG, Castro KM, Troeschel AN, Arora NK, et al
     The rationale for patient-reported outcomes surveillance in cancer and a reproducible method for achieving it.
     Cancer. 2016;122:344-51.
     PubMed     Text format     Abstract available
     
     
     January 2016
104. LITZELMAN K, Kent EE, Rowland JH
     Social factors in informal cancer caregivers: The interrelationships among social stressors, relationship quality, and family functioning in the CanCORS data set.
     Cancer. 2016;122:278-86.
     PubMed     Text format     Abstract available
     
     
     
105. TOROK JA, Palta M, Willett CG, Czito BG, et al
     Nonoperative management of rectal cancer.
     Cancer. 2016;122:34-41.
     PubMed     Text format     Abstract available
     
     
     November 2015
106. NYROP KA, Deal AM, Williams GR, Guerard EJ, et al
     Physical activity communication between oncology providers and patients with early-stage breast, colon, or prostate cancer.
     Cancer. 2015 Nov 13. doi: 10.1002/cncr.29786.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: